A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy.
about
RAS-MAPK pathway epigenetic activation in cancer: miRNAs in actionMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerMicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to TherapyReciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathwayEstrogen withdrawal, increased breast cancer risk and the KRAS-variant.rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese populationPathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients.Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.Polymorphisms in Non-coding RNA Genes and Their Targets Sites as Risk Factors of Sporadic Colorectal Cancer.Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis.Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis.Dietary factors and polymorphisms in vitamin D metabolism genes: the risk and prognosis of colorectal cancer in northeast China.Serum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer.Correlation between DPYD gene variation and KRAS wild type status in colorectal cancer.The Molecular Basis and Therapeutic Potential of Let-7 MicroRNAs against Colorectal Cancer.The Dual Role of MicroRNAs in Colorectal Cancer Progression
P2860
Q26773479-E7C635B7-9B9F-486B-A1EB-ACB1B67F278DQ26775610-6E89C943-8E50-4BE4-8F03-B839C1B50B85Q26801487-4F52022C-5D8C-42EC-AC9F-C51B17AE8ED8Q33599015-B8E9A7FD-D557-4F21-B493-6F5150D4D09CQ36000232-CD55D7C9-287E-49DD-B002-DDBC69806FB7Q36184892-4EF7EC05-D3B2-407E-AF81-874133B09E21Q36187913-0F3CDBD7-1F39-4C45-9463-62B13BAE43A8Q36212703-66EA46C4-8CB3-4523-B534-91AB485E2694Q36671291-F5E1B810-CD1A-4017-BAF3-E2ABF8BE1599Q36847230-01962F14-A1FE-4BA1-963D-0A906D4802E3Q38383212-040610DD-8586-4BA0-920C-3B6040021715Q38826542-47FF2364-B3D5-4F06-983B-4F7C85C824B1Q38940602-3BA78214-FDBA-43FB-9BE3-792BA176469AQ39023377-319EBC8D-BCB8-4B57-9945-BF56C6E9B9D2Q39261789-4CEE2FD7-FD4F-49F6-9B63-6E9BE57ED1BBQ40077906-BE859B05-2C48-44B6-92A4-216125CA2518Q43054579-66E56D30-1F9F-4A0B-888E-4C3739E3D3F0Q50057521-B11684F8-E24D-46CE-AAEF-733EC1BF9F81Q53376512-F5832E29-31C5-4D49-A243-10BCD8AE9584Q55717664-35739067-1FE8-48E1-A840-9685578C6F57Q58729731-244B557F-5A64-4674-B252-0206437FE71A
P2860
A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A let-7 microRNA-binding site ...... ximab/panitumumab monotherapy.
@ast
A let-7 microRNA-binding site ...... ximab/panitumumab monotherapy.
@en
A let-7 microRNA-binding site ...... ximab/panitumumab monotherapy.
@nl
type
label
A let-7 microRNA-binding site ...... ximab/panitumumab monotherapy.
@ast
A let-7 microRNA-binding site ...... ximab/panitumumab monotherapy.
@en
A let-7 microRNA-binding site ...... ximab/panitumumab monotherapy.
@nl
prefLabel
A let-7 microRNA-binding site ...... ximab/panitumumab monotherapy.
@ast
A let-7 microRNA-binding site ...... ximab/panitumumab monotherapy.
@en
A let-7 microRNA-binding site ...... ximab/panitumumab monotherapy.
@nl
P2093
P2860
P50
P921
P1476
A let-7 microRNA-binding site ...... ximab/panitumumab monotherapy.
@en
P2093
Camilla Pilati
David W Salzman
Dongyun Yang
Joanne B Weidhaas
Olivier Bouché
Wendy De Roock
Zenia Saridaki
P2860
P304
P356
10.1158/1078-0432.CCR-14-0348
P407
P577
2014-09-01T00:00:00Z